This study presents a comprehensive multi-omic analysis of 110 healthy individuals to map the natural variation of the human immune system and its relationship with the gut microbiome. Researchers identified two primary axes of immunological variability driven by interferon response signatures, which are critical for antiviral defense and therapy outcomes. One specific axis, termed Immune and Microbiome Concomitant Variation (IMCV), reveals that certain immune cell states—such as activated monocytes and memory T cells—are directly coordinated with microbial metabolic pathways and stool metabolites. These coordinated features, including the production of short-chain fatty acids and polyamines, remain remarkably stable within individuals over long periods. The findings suggest that a person's "interferon setpoint" is influenced by their unique microbiome composition, potentially impacting how they respond to vaccinations and cancer immunotherapies. Ultimately, this research provides a foundational resource for understanding how steady-state biological interactions define health and disease susceptibility.

References:

• Babdor J, Patel R K, Davidson B, et al. Immune-microbiome coordination defines interferon setpoints in healthy humans[J]. Cell, 2026.